Keros Therapeutics Stock (NASDAQ: KROS) stock price, news, charts, stock research, profile.
Open | $54.680 |
Close | $57.860 |
Volume / Avg. | 291.970K / 367.514K |
Day Range | 53.690 - 58.450 |
52 Wk Range | 27.020 - 73.000 |
Market Cap | $2.087B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 45 |
Short Interest | 8.31% |
Days to Cover | 6.27 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Keros Therapeutics (NASDAQ: KROS) through any online brokerage.
Other companies in Keros Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Avidity Biosciences (NASDAQ:RNA), Syndax Pharmaceuticals (NASDAQ:SNDX), Fusion Pharmaceuticals (NASDAQ:FUSN) and TG Therapeutics (NASDAQ:TGTX).
The latest price target for Keros Therapeutics (NASDAQ: KROS) was reported by Piper Sandler on Wednesday, March 27, 2024. The analyst firm set a price target for 105.00 expecting KROS to rise to within 12 months (a possible 81.47% upside). 14 analyst firms have reported ratings in the last year.
The stock price for Keros Therapeutics (NASDAQ: KROS) is $57.86 last updated April 26, 2024 at 4:20 PM EDT.
There are no upcoming dividends for Keros Therapeutics.
Keros Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Keros Therapeutics.
Keros Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.